Emzor Pharmaceuticals, a private Company has listed its N13.7billion 5-Year Series 1 Fixed rate Senior Unsecured Bond, due 2026 on the floor of Nigeria Stock Exchange.
The listing is the first public instrument issued by Emzor Pharmaceuticals and is part of its larger N50billion Debt Issuance Programme, followed its issuance on January 20, 2021 attracting interest from a diverse pool of institutional investors, and was priced at a coupon rate of 10.00 per cent per annum.
With this listing, members of the general public who invested in the bond can now sell their investments, while those who wish to invest can do so.
Speaking on the significance and success of the bond issue, the Group Managing Director, Emzor Pharmaceuticals, Dr. Stella Okoli, said: “This first-time bond issuance is a fantastic achievement for Emzor and is in line with our commitment to facilitate unlimited wellness by delivering quality and affordable medicines for all. The capital raised will, therefore, drive and accelerate our expansion plans, delivering strong growth and margin improvement. We recognise the efforts of the investor community ensuring the success of this bond issuance and commit to uphold their confidence in us as we deliver on our long- term growth strategy.”
